Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a chronic psychotic disorder (such as schizophrenia, schizoaffective disorder, or delusional disorder), OR people who are in good general mental and physical health with no active mental health condition.
- People who can speak and read English fluently.
- People who do not have any significant problems with their hearing or vision.
Who may not be able to join:
- People who have used substances other than cannabis in the last 30 days, based on self-report or a urine test carried out during screening.
- People who have a history of a serious medical condition, a significant neurological illness, or an intellectual disability.
- People who are not able to understand or agree to the informed consent process.
- People joining as a healthy comparison participant who have ever been diagnosed with schizophrenia, schizoaffective disorder, or another chronic psychotic disorder.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juan Molina, MD, VA San Diego Healthcare System, San Diego, CA
Phone: (202) 555-8975
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1-week psychometric reliability of Aperiodic Spectral Biomarkers (neurophysiologic biomarker)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.